These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 692274)

  • 1. The effect of varying 3H-spiperone concentration on its binding parameters.
    Hartley EJ; Seeman P
    Life Sci; 1978 Aug; 23(5):513-7. PubMed ID: 692274
    [No Abstract]   [Full Text] [Related]  

  • 2. 3H-Spiperone binding in normal and schizophrenic post-mortem human brain.
    Mackay AV; Doble A; Bird ED; Spokes EG; Quik M; Iversen LL
    Life Sci; 1978 Aug; 23(5):527-32. PubMed ID: 692277
    [No Abstract]   [Full Text] [Related]  

  • 3. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S; Robson PA
    Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
    Near JA; Mahler HR
    J Neurochem; 1981 Mar; 36(3):1142-51. PubMed ID: 7205263
    [No Abstract]   [Full Text] [Related]  

  • 5. Solubilization of 3H-spiperone binding sites from rat brain.
    Gorissen H; Laduron PM
    Life Sci; 1978 Aug; 23(6):575-9. PubMed ID: 692282
    [No Abstract]   [Full Text] [Related]  

  • 6. [3H] spiroperidol binding to brain neurotransmitter receptors.
    Withy RM; Mayer RJ; Strange PG
    FEBS Lett; 1980 Apr; 112(2):293-5. PubMed ID: 6154601
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of 3H-spiroperidol binding by an endogenous material from brain.
    Lahti RA; Gay DD; Barsuhn C
    Eur J Pharmacol; 1978 Dec; 53(1):117-8. PubMed ID: 738355
    [No Abstract]   [Full Text] [Related]  

  • 8. Two binding sites for 3H-spiroperidol on rat striatal membranes.
    Briley M; Langer SZ
    Eur J Pharmacol; 1978 Aug; 50(3):283-4. PubMed ID: 28956
    [No Abstract]   [Full Text] [Related]  

  • 9. 3H]Spiroperidol binding in bovine caudate nucleus [proceedings.
    Withy RM; Mayer RJ; Strange PG
    Biochem Soc Trans; 1980 Apr; 8(2):181-2. PubMed ID: 6245974
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of [3H]spiperone binding to 5-HT2 receptors of rat cerebral cortex by the calcium antagonists verapamil and D600.
    Taylor JE; Defeudis FV
    Eur J Pharmacol; 1984 Oct; 106(1):215-6. PubMed ID: 6529970
    [No Abstract]   [Full Text] [Related]  

  • 11. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
    Titeler M
    Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding.
    Leysen JE; Gommeren W; Laduron PM
    Biochem Pharmacol; 1978 Feb; 27(3):307-16. PubMed ID: 23126
    [No Abstract]   [Full Text] [Related]  

  • 14. [3H]Spiroperidol (spiperone) binding to a putative dopamine receptor in sheep and steer pituitary and stalk median eminence.
    Cronin MJ; Weiner RI
    Endocrinology; 1979 Feb; 104(2):307-12. PubMed ID: 446362
    [No Abstract]   [Full Text] [Related]  

  • 15. Anomalous properties of [3H]spiperone binding sites in various areas of the rat limbic system.
    Howlett DR; Morris H; Nahorski SR
    Mol Pharmacol; 1979 May; 15(3):506-14. PubMed ID: 492143
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of [3H]spiroperidol binding by in vitro addition of ethanol.
    Hruska RE; Silbergeld EK
    J Neurochem; 1980 Sep; 35(3):750-2. PubMed ID: 7452286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional study of 3H-spiperone binding and the dopamine-sensitive adenylate cyclase in rat brain.
    Quik M; Iversen LL
    Eur J Pharmacol; 1979 Jul; 56(4):323-30. PubMed ID: 477728
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of [3H]spiperone for labelling dopaminergic and serotonergic receptors in bovine caudate nucleus.
    Withy RM; Mayer RJ; Strange PG
    J Neurochem; 1981 Nov; 37(5):1144-54. PubMed ID: 7299393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations.
    De Vries DJ; Beart PM
    Eur J Pharmacol; 1984 Oct; 106(1):133-9. PubMed ID: 6241565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential centrifugation of 3H-apomorphine and 3H-spiroperidol binding sites.
    Titeler M; Seeman P; Henn F
    Eur J Pharmacol; 1978 Oct; 51(4):459-60. PubMed ID: 710514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.